Validation of a classification system for treatment-related mortality in children with cancer
BackgroundDeath not directly due to cancer has been termed ‘treatment-related mortality’ (TRM). Appreciating the differences between TRM and disease-related death is critical in directing strategies to improve supportive care, interventions delivered or disease progression. Recently, a global collab...
Gespeichert in:
Veröffentlicht in: | BMJ paediatrics open 2017-10, Vol.1 (1), p.e000082-e000082 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e000082 |
---|---|
container_issue | 1 |
container_start_page | e000082 |
container_title | BMJ paediatrics open |
container_volume | 1 |
creator | Hassan, Hadeel Rompola, Menie Glaser, Adam Woolf Kinsey, Sally Elizabeth Phillips, Robert Stephen |
description | BackgroundDeath not directly due to cancer has been termed ‘treatment-related mortality’ (TRM). Appreciating the differences between TRM and disease-related death is critical in directing strategies to improve supportive care, interventions delivered or disease progression. Recently, a global collaboration developed and validated a consensus-based classification tool and attribution system.ObjectivesTo evaluate the reliability of the newly developed consensus-based definition of TRM and explore the use of the cause-of-death attribution system outside the centre it was initially validated (Toronto, Canada). In the initial study, reviewers listed multiple causes of death. In this study, reviewers identified a primary cause for simplicity.SettingThe paediatric haematology and oncology department at Leeds Teaching Hospital in Leeds, UK.ParticipantsTwo consultants and two clinical research associates (CRAs).MethodsThirty medical records of the most recent deaths in children with cancer, 2 and 4 weeks prior to death, were anonymised and presented to the participants. Reviewers independently classified deaths as ‘treatment related mortality’ or ‘not treatment related’ according to the algorithm developed. When TRM occurred, reviewers applied the cause-of-death attribution system to identify the primary cause of death. Inter-relater reliability was assessed using the kappa statistic (k).Main outcomeInter-relater reliability between CRA and consultants.ResultsReliability of the classification was deemed ‘very good’ between CRA and consultants (k=0.86, 95% CI 0.72 to 0.97). Ten deaths were classified as TRM, of which infection was the most frequent cause identified. Reviewers disagreed on the primary cause of death (eg, respiratory vs infection) when applying the cause-of-death attribution system in six cases and probable and possible causes in four cases. The study identified how the algorithm may not detect TRM in patients receiving non-curative therapy.ConclusionsThe classification and cause of death attribution system could be implemented in different healthcare settings. Adaptation of the classification tool in patients receiving non-curative interventions and the cause of death attribution system should be considered. |
doi_str_mv | 10.1136/bmjpo-2017-000082 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5862234</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2552743498</sourcerecordid><originalsourceid>FETCH-LOGICAL-b464t-1a8411066e9466273700c193e124e277adf9f2837dff22989681a08d13dacb9a3</originalsourceid><addsrcrecordid>eNqNkU1rHSEYhaWkNCHND-gmCNl00Wn11fFjUygh_YBAN213RbyO5nqZGW_Um3D_fU0mDWlXcaO8PufwHg5Cbyh5TykTH1bTZps6IFR2pB0FL9ARMK07LSUcPHkfopNSNg2hWmnewyt0CFowSYEcod-_7BgHW2OacQrYYjfaUmKIbpmVfal-wiFlXLO3dfJz7bIfbfUDnlKuTV73OM7YreM4ZD_j21jX2NnZ-fwavQx2LP7k4T5GPz9f_Dj_2l1-__Lt_NNlt-KC145axSklQnjNhQDJJCGOauYpcA9S2iHoAIrJIQSAlkIoaokaKBusW2nLjtHHxXe7W01-cG3JbEezzXGyeW-SjebfnzmuzVW6Mb0SAIw3g7cPBjld73ypZorF-XG0s0-7YoAAJ7RX9-jZf-gm7fLc4hnoe5Ccca0aRRfK5VRK9uFxGUrMXX_mvj9z159Z-mua06cpHhV_22rAuwVo2mf4_QHZKaWk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2552743498</pqid></control><display><type>article</type><title>Validation of a classification system for treatment-related mortality in children with cancer</title><source>BMJ Open Access Journals</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Hassan, Hadeel ; Rompola, Menie ; Glaser, Adam Woolf ; Kinsey, Sally Elizabeth ; Phillips, Robert Stephen</creator><creatorcontrib>Hassan, Hadeel ; Rompola, Menie ; Glaser, Adam Woolf ; Kinsey, Sally Elizabeth ; Phillips, Robert Stephen</creatorcontrib><description>BackgroundDeath not directly due to cancer has been termed ‘treatment-related mortality’ (TRM). Appreciating the differences between TRM and disease-related death is critical in directing strategies to improve supportive care, interventions delivered or disease progression. Recently, a global collaboration developed and validated a consensus-based classification tool and attribution system.ObjectivesTo evaluate the reliability of the newly developed consensus-based definition of TRM and explore the use of the cause-of-death attribution system outside the centre it was initially validated (Toronto, Canada). In the initial study, reviewers listed multiple causes of death. In this study, reviewers identified a primary cause for simplicity.SettingThe paediatric haematology and oncology department at Leeds Teaching Hospital in Leeds, UK.ParticipantsTwo consultants and two clinical research associates (CRAs).MethodsThirty medical records of the most recent deaths in children with cancer, 2 and 4 weeks prior to death, were anonymised and presented to the participants. Reviewers independently classified deaths as ‘treatment related mortality’ or ‘not treatment related’ according to the algorithm developed. When TRM occurred, reviewers applied the cause-of-death attribution system to identify the primary cause of death. Inter-relater reliability was assessed using the kappa statistic (k).Main outcomeInter-relater reliability between CRA and consultants.ResultsReliability of the classification was deemed ‘very good’ between CRA and consultants (k=0.86, 95% CI 0.72 to 0.97). Ten deaths were classified as TRM, of which infection was the most frequent cause identified. Reviewers disagreed on the primary cause of death (eg, respiratory vs infection) when applying the cause-of-death attribution system in six cases and probable and possible causes in four cases. The study identified how the algorithm may not detect TRM in patients receiving non-curative therapy.ConclusionsThe classification and cause of death attribution system could be implemented in different healthcare settings. Adaptation of the classification tool in patients receiving non-curative interventions and the cause of death attribution system should be considered.</description><identifier>ISSN: 2399-9772</identifier><identifier>EISSN: 2399-9772</identifier><identifier>DOI: 10.1136/bmjpo-2017-000082</identifier><identifier>PMID: 29637120</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Cancer ; Classification ; Collaboration ; Consultants ; Hematology ; Infections ; Mortality ; Oncology ; Original ; Patients ; Pediatrics ; Tumors</subject><ispartof>BMJ paediatrics open, 2017-10, Vol.1 (1), p.e000082-e000082</ispartof><rights>Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.</rights><rights>2017 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b464t-1a8411066e9466273700c193e124e277adf9f2837dff22989681a08d13dacb9a3</citedby><cites>FETCH-LOGICAL-b464t-1a8411066e9466273700c193e124e277adf9f2837dff22989681a08d13dacb9a3</cites><orcidid>0000-0002-8266-1659</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmjpaedsopen.bmj.com/content/1/1/e000082.full.pdf$$EPDF$$P50$$Gbmj$$Hfree_for_read</linktopdf><linktohtml>$$Uhttp://bmjpaedsopen.bmj.com/content/1/1/e000082.full$$EHTML$$P50$$Gbmj$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,27554,27555,27929,27930,53796,53798,77606,77637</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29637120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hassan, Hadeel</creatorcontrib><creatorcontrib>Rompola, Menie</creatorcontrib><creatorcontrib>Glaser, Adam Woolf</creatorcontrib><creatorcontrib>Kinsey, Sally Elizabeth</creatorcontrib><creatorcontrib>Phillips, Robert Stephen</creatorcontrib><title>Validation of a classification system for treatment-related mortality in children with cancer</title><title>BMJ paediatrics open</title><addtitle>BMJ Paediatr Open</addtitle><description>BackgroundDeath not directly due to cancer has been termed ‘treatment-related mortality’ (TRM). Appreciating the differences between TRM and disease-related death is critical in directing strategies to improve supportive care, interventions delivered or disease progression. Recently, a global collaboration developed and validated a consensus-based classification tool and attribution system.ObjectivesTo evaluate the reliability of the newly developed consensus-based definition of TRM and explore the use of the cause-of-death attribution system outside the centre it was initially validated (Toronto, Canada). In the initial study, reviewers listed multiple causes of death. In this study, reviewers identified a primary cause for simplicity.SettingThe paediatric haematology and oncology department at Leeds Teaching Hospital in Leeds, UK.ParticipantsTwo consultants and two clinical research associates (CRAs).MethodsThirty medical records of the most recent deaths in children with cancer, 2 and 4 weeks prior to death, were anonymised and presented to the participants. Reviewers independently classified deaths as ‘treatment related mortality’ or ‘not treatment related’ according to the algorithm developed. When TRM occurred, reviewers applied the cause-of-death attribution system to identify the primary cause of death. Inter-relater reliability was assessed using the kappa statistic (k).Main outcomeInter-relater reliability between CRA and consultants.ResultsReliability of the classification was deemed ‘very good’ between CRA and consultants (k=0.86, 95% CI 0.72 to 0.97). Ten deaths were classified as TRM, of which infection was the most frequent cause identified. Reviewers disagreed on the primary cause of death (eg, respiratory vs infection) when applying the cause-of-death attribution system in six cases and probable and possible causes in four cases. The study identified how the algorithm may not detect TRM in patients receiving non-curative therapy.ConclusionsThe classification and cause of death attribution system could be implemented in different healthcare settings. Adaptation of the classification tool in patients receiving non-curative interventions and the cause of death attribution system should be considered.</description><subject>Cancer</subject><subject>Classification</subject><subject>Collaboration</subject><subject>Consultants</subject><subject>Hematology</subject><subject>Infections</subject><subject>Mortality</subject><subject>Oncology</subject><subject>Original</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Tumors</subject><issn>2399-9772</issn><issn>2399-9772</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>ACMMV</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkU1rHSEYhaWkNCHND-gmCNl00Wn11fFjUygh_YBAN213RbyO5nqZGW_Um3D_fU0mDWlXcaO8PufwHg5Cbyh5TykTH1bTZps6IFR2pB0FL9ARMK07LSUcPHkfopNSNg2hWmnewyt0CFowSYEcod-_7BgHW2OacQrYYjfaUmKIbpmVfal-wiFlXLO3dfJz7bIfbfUDnlKuTV73OM7YreM4ZD_j21jX2NnZ-fwavQx2LP7k4T5GPz9f_Dj_2l1-__Lt_NNlt-KC145axSklQnjNhQDJJCGOauYpcA9S2iHoAIrJIQSAlkIoaokaKBusW2nLjtHHxXe7W01-cG3JbEezzXGyeW-SjebfnzmuzVW6Mb0SAIw3g7cPBjld73ypZorF-XG0s0-7YoAAJ7RX9-jZf-gm7fLc4hnoe5Ccca0aRRfK5VRK9uFxGUrMXX_mvj9z159Z-mua06cpHhV_22rAuwVo2mf4_QHZKaWk</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Hassan, Hadeel</creator><creator>Rompola, Menie</creator><creator>Glaser, Adam Woolf</creator><creator>Kinsey, Sally Elizabeth</creator><creator>Phillips, Robert Stephen</creator><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8266-1659</orcidid></search><sort><creationdate>20171001</creationdate><title>Validation of a classification system for treatment-related mortality in children with cancer</title><author>Hassan, Hadeel ; Rompola, Menie ; Glaser, Adam Woolf ; Kinsey, Sally Elizabeth ; Phillips, Robert Stephen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b464t-1a8411066e9466273700c193e124e277adf9f2837dff22989681a08d13dacb9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Cancer</topic><topic>Classification</topic><topic>Collaboration</topic><topic>Consultants</topic><topic>Hematology</topic><topic>Infections</topic><topic>Mortality</topic><topic>Oncology</topic><topic>Original</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hassan, Hadeel</creatorcontrib><creatorcontrib>Rompola, Menie</creatorcontrib><creatorcontrib>Glaser, Adam Woolf</creatorcontrib><creatorcontrib>Kinsey, Sally Elizabeth</creatorcontrib><creatorcontrib>Phillips, Robert Stephen</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ paediatrics open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hassan, Hadeel</au><au>Rompola, Menie</au><au>Glaser, Adam Woolf</au><au>Kinsey, Sally Elizabeth</au><au>Phillips, Robert Stephen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of a classification system for treatment-related mortality in children with cancer</atitle><jtitle>BMJ paediatrics open</jtitle><addtitle>BMJ Paediatr Open</addtitle><date>2017-10-01</date><risdate>2017</risdate><volume>1</volume><issue>1</issue><spage>e000082</spage><epage>e000082</epage><pages>e000082-e000082</pages><issn>2399-9772</issn><eissn>2399-9772</eissn><abstract>BackgroundDeath not directly due to cancer has been termed ‘treatment-related mortality’ (TRM). Appreciating the differences between TRM and disease-related death is critical in directing strategies to improve supportive care, interventions delivered or disease progression. Recently, a global collaboration developed and validated a consensus-based classification tool and attribution system.ObjectivesTo evaluate the reliability of the newly developed consensus-based definition of TRM and explore the use of the cause-of-death attribution system outside the centre it was initially validated (Toronto, Canada). In the initial study, reviewers listed multiple causes of death. In this study, reviewers identified a primary cause for simplicity.SettingThe paediatric haematology and oncology department at Leeds Teaching Hospital in Leeds, UK.ParticipantsTwo consultants and two clinical research associates (CRAs).MethodsThirty medical records of the most recent deaths in children with cancer, 2 and 4 weeks prior to death, were anonymised and presented to the participants. Reviewers independently classified deaths as ‘treatment related mortality’ or ‘not treatment related’ according to the algorithm developed. When TRM occurred, reviewers applied the cause-of-death attribution system to identify the primary cause of death. Inter-relater reliability was assessed using the kappa statistic (k).Main outcomeInter-relater reliability between CRA and consultants.ResultsReliability of the classification was deemed ‘very good’ between CRA and consultants (k=0.86, 95% CI 0.72 to 0.97). Ten deaths were classified as TRM, of which infection was the most frequent cause identified. Reviewers disagreed on the primary cause of death (eg, respiratory vs infection) when applying the cause-of-death attribution system in six cases and probable and possible causes in four cases. The study identified how the algorithm may not detect TRM in patients receiving non-curative therapy.ConclusionsThe classification and cause of death attribution system could be implemented in different healthcare settings. Adaptation of the classification tool in patients receiving non-curative interventions and the cause of death attribution system should be considered.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29637120</pmid><doi>10.1136/bmjpo-2017-000082</doi><orcidid>https://orcid.org/0000-0002-8266-1659</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2399-9772 |
ispartof | BMJ paediatrics open, 2017-10, Vol.1 (1), p.e000082-e000082 |
issn | 2399-9772 2399-9772 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5862234 |
source | BMJ Open Access Journals; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Cancer Classification Collaboration Consultants Hematology Infections Mortality Oncology Original Patients Pediatrics Tumors |
title | Validation of a classification system for treatment-related mortality in children with cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T23%3A40%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20a%20classification%20system%20for%20treatment-related%20mortality%20in%20children%20with%20cancer&rft.jtitle=BMJ%20paediatrics%20open&rft.au=Hassan,%20Hadeel&rft.date=2017-10-01&rft.volume=1&rft.issue=1&rft.spage=e000082&rft.epage=e000082&rft.pages=e000082-e000082&rft.issn=2399-9772&rft.eissn=2399-9772&rft_id=info:doi/10.1136/bmjpo-2017-000082&rft_dat=%3Cproquest_pubme%3E2552743498%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2552743498&rft_id=info:pmid/29637120&rfr_iscdi=true |